Cases & Deals

  • Home
  • Practices
  • Nanobiotix completes €21.3 million private placement of new shares

Share

Nanobiotix completes €21.3 million private placement of new shares

March 2016

Client(s) Nanobiotix SA

Jones Day advised Nanobiotix SA, an oncology focused nanomedicine company listed on the regulated market of Euronext in Paris, in connection with its €21.3 million (US$26.1 million) private placement of new shares to U.S. and European investors.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.